FDA authorizes first breath test for COVID-19

The FDA recently announced that it has issued an emergency use authorization for the first diagnostic test that detects SARS-CoV-2 in breath samples.
The InspectIR COVID-19 Breathalyzer test (InspectIR Systems) provides results in under 3 minutes, according to an FDA press release.
Jeff Shuren, MD, JD, the director of the FDA’s Center for Devices and Radiological Health, said the authorization “is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
“The FDA continues to support the development of novel COVID-19 tests with the goal of

The FDA recently announced that it has issued an emergency use authorization for the first diagnostic test that detects SARS-CoV-2 in breath samples.
The InspectIR COVID-19 Breathalyzer test (InspectIR Systems) provides results in under 3 minutes, according to an FDA press release.
Jeff Shuren, MD, JD, the director of the FDA’s Center for Devices and Radiological Health, said the authorization “is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
“The FDA continues to support the development of novel COVID-19 tests with the goal of